FDA Inspection 1230770 — Center for Reproductive Health Fertility Laboratory of Nashville

Center for Reproductive Health Fertility Laboratory of Nashville — FEI 3005057005

The FDA completed an inspection of Center for Reproductive Health Fertility Laboratory of Nashville on February 23, 2024 in Nashville, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 23, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Nashville, TN (United States)

Citations

IDCFRDescription
1224221 CFR 1271.55(c)Name and personal info on accompanying records